Navellier & Associates’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-17,159
| Closed | -$2.95M | – | 343 |
|
|
2024
Q3 | $2.95M | Sell |
17,159
-4,147
| -19% | -$713K | 0.4% | 67 |
|
|
2024
Q2 | $3.28M | Buy |
+21,306
| New | +$3.28M | 0.39% | 65 |
|
|
2023
Q4 | – | Sell |
-23,276
| Closed | -$3.41M | – | 333 |
|
|
2023
Q3 | $3.41M | Buy |
23,276
+375
| +2% | +$54.9K | 0.58% | 54 |
|
|
2023
Q2 | $3.51M | Buy |
+22,901
| New | +$3.51M | 0.68% | 57 |
|
|
2021
Q2 | – | Sell |
-36,421
| Closed | -$5.85M | – | 314 |
|
|
2021
Q1 | $5.85M | Buy |
+36,421
| New | +$5.85M | 1.05% | 29 |
|
|
2019
Q2 | – | Sell |
-127,463
| Closed | -$19.2M | – | 286 |
|
|
2019
Q1 | $19.2M | Buy |
+127,463
| New | +$19.2M | 2.98% | 5 |
|
|
2018
Q4 | – | Sell |
-170,264
| Closed | -$27M | – | 252 |
|
|
2018
Q3 | $27M | Buy |
170,264
+134
| +0.1% | +$21.2K | 3.49% | 2 |
|
|
2018
Q2 | $23.8M | Sell |
170,130
-715
| -0.4% | -$100K | 3.32% | 1 |
|
|
2018
Q1 | $22.7M | Buy |
+170,845
| New | +$22.7M | 3.44% | 1 |
|
|
2017
Q4 | – | Sell |
-3,210
| Closed | -$398K | – | 301 |
|
|
2017
Q3 | $398K | Sell |
3,210
-156,498
| -98% | -$19.4M | 0.08% | 168 |
|
|
2017
Q2 | $18.2M | Buy |
+159,708
| New | +$18.2M | 2.72% | 2 |
|
|
2017
Q1 | – | Sell |
-67,365
| Closed | -$6.12M | – | 288 |
|
|
2016
Q4 | $6.12M | Buy |
67,365
+21,937
| +48% | +$1.99M | 1.01% | 24 |
|
|
2016
Q3 | $4.53M | Buy |
+45,428
| New | +$4.53M | 0.65% | 54 |
|
|
2015
Q2 | – | Sell |
-18,248
| Closed | -$2.16M | – | 363 |
|
|
2015
Q1 | $2.16M | Buy |
+18,248
| New | +$2.16M | 0.2% | 60 |
|
|
2014
Q4 | – | Sell |
-16,035
| Closed | -$1.47M | – | 337 |
|
|
2014
Q3 | $1.47M | Buy |
+16,035
| New | +$1.47M | 0.07% | 72 |
|